109 related articles for article (PubMed ID: 29502025)
1. Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design.
Pal M; Easton NM; Yaphe H; Bearne SL
Bioorg Chem; 2018 Apr; 77():640-650. PubMed ID: 29502025
[TBL] [Abstract][Full Text] [Related]
2. Rational design and synthesis of substrate-product analogue inhibitors of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis.
Pal M; Khanal M; Marko R; Thirumalairajan S; Bearne SL
Chem Commun (Camb); 2016 Feb; 52(13):2740-3. PubMed ID: 26759836
[TBL] [Abstract][Full Text] [Related]
3. Substrate-product analogue inhibitors of isoleucine 2-epimerase from Lactobacillus buchneri by rational design.
Sorbara NT; MacMillan JWM; McCluskey GD; Bearne SL
Org Biomol Chem; 2019 Sep; 17(37):8618-8627. PubMed ID: 31528932
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
Carnell AJ; Kirk R; Smith M; McKenna S; Lian LY; Gibson R
ChemMedChem; 2013 Oct; 8(10):1643-7. PubMed ID: 23929631
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-arylthiopropanoyl-CoA inhibitors of α-methylacyl-CoA racemase 1A (AMACR; P504S) as potential anti-prostate cancer agents.
Yevglevskis M; Nathubhai A; Wadda K; Lee GL; Al-Rawi S; Jiao T; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2019 Nov; 92():103263. PubMed ID: 31536953
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure-activity relationships.
Petrova YD; Wadda K; Nathubhai A; Yevglevskis M; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2019 Nov; 92():103264. PubMed ID: 31536955
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of rationally designed AMACR 1A inhibitors.
Yevglevskis M; Lee GL; Nathubhai A; Petrova YD; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2018 Sep; 79():145-154. PubMed ID: 29751320
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of serine and proline racemases by substrate-product analogues.
Harty M; Nagar M; Atkinson L; Legay CM; Derksen DJ; Bearne SL
Bioorg Med Chem Lett; 2014 Jan; 24(1):390-3. PubMed ID: 24314397
[TBL] [Abstract][Full Text] [Related]
9. A study on the AMACR catalysed elimination reaction and its application to inhibitor testing.
Yevglevskis M; Lee GL; Sun J; Zhou S; Sun X; Kociok-Köhn G; James TD; Woodman TJ; Lloyd MD
Org Biomol Chem; 2016 Jan; 14(2):612-622. PubMed ID: 26537174
[TBL] [Abstract][Full Text] [Related]
10. A novel colorimetric assay for α-methylacyl-CoA racemase 1A (AMACR; P504S) utilizing the elimination of 2,4-dinitrophenolate.
Yevglevskis M; Lee GL; Nathubhai A; Petrova YD; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Chem Commun (Camb); 2017 May; 53(37):5087-5090. PubMed ID: 28338138
[TBL] [Abstract][Full Text] [Related]
11. A continuous assay for alpha-methylacyl-coenzyme A racemase using circular dichroism.
Ouazia D; Bearne SL
Anal Biochem; 2010 Mar; 398(1):45-51. PubMed ID: 19854148
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors.
Carnell AJ; Hale I; Denis S; Wanders RJ; Isaacs WB; Wilson BA; Ferdinandusse S
J Med Chem; 2007 May; 50(11):2700-7. PubMed ID: 17477519
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibition of mandelate racemase by a fluorinated substrate-product analogue with a novel binding mode.
Nagar M; Lietzan AD; St Maurice M; Bearne SL
Biochemistry; 2014 Feb; 53(7):1169-78. PubMed ID: 24472022
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of substrate-product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism.
Bearne SL
Methods Enzymol; 2023; 690():397-444. PubMed ID: 37858537
[TBL] [Abstract][Full Text] [Related]
15. The catalysis of the 1,1-proton transfer by alpha-methyl-acyl-CoA racemase is coupled to a movement of the fatty acyl moiety over a hydrophobic, methionine-rich surface.
Bhaumik P; Schmitz W; Hassinen A; Hiltunen JK; Conzelmann E; Wierenga RK
J Mol Biol; 2007 Apr; 367(4):1145-61. PubMed ID: 17320106
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold.
Savolainen K; Bhaumik P; Schmitz W; Kotti TJ; Conzelmann E; Wierenga RK; Hiltunen JK
J Biol Chem; 2005 Apr; 280(13):12611-20. PubMed ID: 15632186
[TBL] [Abstract][Full Text] [Related]
17. New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors.
Morgenroth A; Urusova EA; Dinger C; Al-Momani E; Kull T; Glatting G; Frauendorf H; Jahn O; Mottaghy FM; Reske SN; Zlatopolskiy BD
Chemistry; 2011 Aug; 17(36):10144-50. PubMed ID: 21812041
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary X-ray diffraction studies of an alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis.
Bhaumik P; Kursula P; Ratas V; Conzelmann E; Hiltunen JK; Schmitz W; Wierenga RK
Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):353-5. PubMed ID: 12554951
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mandelate racemase by the substrate-intermediate-product analogue 1,1-diphenyl-1-hydroxymethylphosphonate.
Burley RK; Bearne SL
Bioorg Med Chem Lett; 2005 Oct; 15(19):4342-4. PubMed ID: 16039120
[TBL] [Abstract][Full Text] [Related]
20. α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S.
Lloyd MD; Yevglevskis M; Lee GL; Wood PJ; Threadgill MD; Woodman TJ
Prog Lipid Res; 2013 Apr; 52(2):220-30. PubMed ID: 23376124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
